Success Metrics

Active Trials

3(75%)

Phase Distribution

Ph phase_2

25%

Ph phase_1

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 2Efficacy & side effects

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Recruiting3

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 2

Trials by Phase

Phase 13 (75.0%)

Phase 21 (25.0%)

Trials by Status

not_yet_recruiting125%

recruiting375%

Recent Activity

3 active trials

Showing 4 of 4

not_yet_recruitingphase_2

Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

NCT07486310

recruitingphase_1

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

NCT07093814

recruitingphase_1

A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

NCT06368921

recruitingphase_1

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

NCT06826313

Clinical Trials (4)

Showing 4 of 4 trials

NCT07486310Phase 2

Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial

Not Yet Recruiting

NCT07093814Phase 1

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Recruiting

NCT06368921Phase 1

A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

Recruiting

NCT06826313Phase 1

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Recruiting

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4